Cui A, Du Y, Hou C, Zhang L, Sun L, He H
Front Oncol. 2023; 13:1234961.
PMID: 37849817
PMC: 10577444.
DOI: 10.3389/fonc.2023.1234961.
Xing C, Lin M, Luo W, Chen L, Wu S, Cai Y
Transl Cancer Res. 2023; 12(4):848-858.
PMID: 37180645
PMC: 10174760.
DOI: 10.21037/tcr-22-2621.
Sahoo Sr B, Padhi S, Patra A, Mahapatra B, Mishra T, Mishra S
Cureus. 2023; 15(3):e36442.
PMID: 37090370
PMC: 10115659.
DOI: 10.7759/cureus.36442.
Xue Y, Li G, Xie T, Xu H, Xu T, Li Z
Eur Arch Otorhinolaryngol. 2023; 280(7):3097-3106.
PMID: 37079074
DOI: 10.1007/s00405-023-07943-9.
Dong Y, Zhang J, Lam S, Zhang X, Liu A, Teng X
Cancers (Basel). 2023; 15(7).
PMID: 37046693
PMC: 10093711.
DOI: 10.3390/cancers15072032.
Postoperative Intensity-Modulated Radiation Therapy for Myoepithelial Carcinoma in the Parotid Gland.
Nakatsu K, Kishi T, Kusano J, Hiratsuka Y, Ishigaki T
Cureus. 2022; 14(1):e21197.
PMID: 35047316
PMC: 8759982.
DOI: 10.7759/cureus.21197.
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.
Tang L, Chen Y, Chen C, Chen M, Chen N, Chen X
Cancer Commun (Lond). 2021; 41(11):1195-1227.
PMID: 34699681
PMC: 8626602.
DOI: 10.1002/cac2.12218.
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial.
Huang X, Chen X, Zhao C, Wang J, Wang K, Wang L
Front Oncol. 2020; 10:1314.
PMID: 32850414
PMC: 7426506.
DOI: 10.3389/fonc.2020.01314.
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang C, Guo R, Li J, Xu C, Mao Y, Tian L
Eur Radiol. 2019; 30(2):816-822.
PMID: 31650266
DOI: 10.1007/s00330-019-06500-5.
PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
Jiang F, Yu W, Zeng F, Cheng G, Xu J, Yang S
BMC Cancer. 2019; 19(1):503.
PMID: 31138162
PMC: 6537411.
DOI: 10.1186/s12885-019-5689-y.
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era.
Tang L, Liang S, Huang C, Zhang F, Xu C, Mao Y
Cancer Med. 2019; 8(5):2213-2222.
PMID: 30950240
PMC: 6536995.
DOI: 10.1002/cam4.2131.
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C, Kitpanit S, Prayongrat A, Kannarunimit D, Netsawang B, Chakkabat C
J Radiat Res. 2018; 59(4):446-455.
PMID: 29750261
PMC: 6054176.
DOI: 10.1093/jrr/rry036.
A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C, Prayongrat A, Kannarunimit D, Chakkabat C, Netsawang B, Kitpanit S
Strahlenther Onkol. 2018; 194(5):375-385.
PMID: 29302704
DOI: 10.1007/s00066-017-1251-5.
Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy.
Chao H, Liu S, Tsao C, Lin K, Lee S, Lo C
J Radiat Res. 2017; 58(5):654-660.
PMID: 28992206
PMC: 5737244.
DOI: 10.1093/jrr/rrx034.
Pretreatment Nomograms for Local and Regional Recurrence after Radical Radiation Therapy for Primary Nasopharyngeal Carcinoma.
Chen F, Lin L, Qi Z, Zhou G, Guo R, Hu J
J Cancer. 2017; 8(13):2595-2603.
PMID: 28900497
PMC: 5595089.
DOI: 10.7150/jca.20255.
Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study.
Xu Y, Chen X, Zhang M, Xiao Y, Zong J, Guo Q
Cancer Med. 2017; 6(10):2213-2221.
PMID: 28879654
PMC: 5633546.
DOI: 10.1002/cam4.1154.
Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.
Johansen S, Norman M, Dale E, Amdal C, Furre T, Malinen E
Radiat Oncol. 2017; 12(1):87.
PMID: 28545588
PMC: 5444101.
DOI: 10.1186/s13014-017-0829-5.
Comparison between the four-field box and field-in-field techniques for conformal radiotherapy of the esophagus using dose-volume histograms and normal tissue complication probabilities.
Allaveisi F, Moghadam A
Jpn J Radiol. 2017; 35(6):327-334.
PMID: 28421397
DOI: 10.1007/s11604-017-0637-8.
Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X, Wei Y, Tao H, Zhu J, Li B
Oncotarget. 2017; 8(16):27529-27540.
PMID: 28404877
PMC: 5432355.
DOI: 10.18632/oncotarget.16770.
Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
Lin J, Lv X, Niu M, Liu L, Chen J, Xie F
Neuroimage Clin. 2017; 14:610-621.
PMID: 28348952
PMC: 5357686.
DOI: 10.1016/j.nicl.2017.02.025.